Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Orthostatic Intolerance After Bariatric Surgery
NCT03808740Phase 1Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jul 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of atomoxetine in orthostatic intolerance, sponsored by Vanderbilt University Medical Center. Started Jul 2018; status: terminated.
02
Drugs
atomoxetine
03
Conditions
orthostatic intolerance
Beyond the preview
Go deeper on NCT03808740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03808740.